Literature DB >> 35734497

SURGICAL AND SEIZURE TREATMENT OUTCOMES IN ADULT DYSEMBRYOPLASTIC NEUROEPITHELIAL TUMORS: A CASE SERIES.

Tomislav Sajko1, Krešimir Rotim1, Mia Jurilj1, Ante Rotim1, Bruno Splavski1, Ivana Jurčić Čulina1.   

Abstract

Dysembryoplastic neuroepithelial tumors (DNETs) are benign neoplasms classified in the category of glioneuronal tumors. The estimated incidence of DNETs is 0.03 per 100,000 person per year with the age peak in a range between 10 and 14 years, and decreasing dramatically with increasing age. They are seldom diagnosed in persons above 20 years of age, being a cause of tumor-related intractable epilepsy that begins in childhood or adolescence. They have been proven to be the second most common type of epileptogenic tumors in pediatric population. These rare tumors cause chronic drug-resistant partial complex seizures with or without secondary generalization. Herein, we provide institutional case series of six adult patients with temporal lobe DNET presenting with complex partial seizures. Lesionectomy was performed with tumor resection in toto in three patients. In another three, partial resection was performed, whereas tumor remnant was left intact to avoid possible basal ganglia damage. All patients were seizure free postoperatively. Lesionectomy alone in temporal lobe epilepsy was associated with less favorable outcome than anterior temporal lobectomy. Total tumor removal is considered a major prognostic factor in most studies.

Entities:  

Keywords:  Dysembryoplastic neuroepithelial tumor; Outcome; Seizure; Surgery

Mesh:

Year:  2021        PMID: 35734497      PMCID: PMC9196212          DOI: 10.20471/acc.2021.60.04.09

Source DB:  PubMed          Journal:  Acta Clin Croat        ISSN: 0353-9466            Impact factor:   0.932


Introduction

Dysembryoplastic neuroepithelial tumors (DNETs) are benign tumors first described by Daumas-Duport et al. (). The World Health Organization (WHO) includes DNETs in the category of neuronal and mixed neuronal-glial tumors, corresponding to WHO grade 1 (). Four DNET histologic subtypes have been described (-). They represent 1.2% of all neuroepithelial tumors resected in patients under the age of 20 years (). In epilepsy surgery series, the prevalence of DNETs ranges from 0.8% to 19% (-). DNETs are found in about 20% of histologic diagnoses in adult epilepsy surgery centers (). The most common seizure type with DNETs is complex partial seizures with epileptogenic zone in the temporal lobe (, , ). Surgery is associated with very good prognosis and low recurrence risk (). Lesionectomy alone in temporal lobe epilepsy is associated with less favorable outcome than anterior temporal lobectomy. Herein, we describe institutional series of six adult patients with such tumors presenting with complex partial seizures, and discuss postoperative surgical and seizure outcome.

Case Series

Six adult patients with DNETs admitted to Department of Neurosurgery, Sestre milosrdnice University Hospital Center during the 2012-2018 period were included. Patient characteristics are summarized in Table 1. All patients were right-handed and their mean age was 29.8 (range, 19 to 43) years. All patients underwent presurgical epileptogenic, neuroradiological and neurophysiological examination. All patients had complex partial seizures with a mean duration of 13.2 years. Four patients were on one antiepileptic drug (AED) and two patients on two AEDs prior to surgery. Preoperative neurophysiological examination revealed normal results in four younger patients, but reduced verbal memory in two older patients.
Table 1

Patient characteristics

CaseSexAge (yrs)Location of DNETSeizure typeNo. of AEDsSeizureSurgery
Preop/postop outcome
1M20Left temporalCP1/0SFLesionectomy
2M27Left temporalCP1/1SFLesionectomy
3F30Left temporalCP2/1SFLesionectomy
4F19Right temporalCP1/0SFLesionectomy
5M43Left temporalCP2/2SFLesionectomy
6M40Right temporalCP2/2SFLesionectomy

DNET = dysembryoplastic neuroepithelial tumor; AEDs = antiepileptic drugs; CP = complex partial; SF = seizure free

DNET = dysembryoplastic neuroepithelial tumor; AEDs = antiepileptic drugs; CP = complex partial; SF = seizure free Four patients had DNET in the left temporal lobe and two in the right temporal lobe. In all patients, DNET involved the uncus and amygdala without hippocampus involvement (Fig. 1A, B).
Fig. 1

Preoperative magnetic resonance imaging (MRI) of the brain (T2 axial weighted image): pathologic lesion in the region of the left-sided uncus and amygdala. Note the increased volume of the uncus and amygdala and absence of perilesional edema (A). Note the blurring and hyperintense signal of the left amygdala on coronal FLAIR axial MRI reformations (B).

Preoperative magnetic resonance imaging (MRI) of the brain (T2 axial weighted image): pathologic lesion in the region of the left-sided uncus and amygdala. Note the increased volume of the uncus and amygdala and absence of perilesional edema (A). Note the blurring and hyperintense signal of the left amygdala on coronal FLAIR axial MRI reformations (B). Surgery was performed and tumor resection in toto was achieved in three patients (Fig. 2). In another three patients, subtotal resection was performed in order to avoid basal ganglia damage. Postoperative period was uneventful, without complications.
Fig. 2

Postoperative magnetic resonance imaging of the brain (T2 axial weighted image): resection area involving the left uncus and amygdala.

Postoperative magnetic resonance imaging of the brain (T2 axial weighted image): resection area involving the left uncus and amygdala. Histopathologic examination showed complex DNET type in all six cases. Follow-up was 24 months. Postoperatively, all six patients were seizure-free, and AEDs were withdrawn in two youngest patients.

Discussion

Epilepsy onset in late childhood, complex partial seizures concordant with tumor location, and male predominance are characteristic of DNET (, ). The typical magnetic resonance imaging (MRI) pattern consists of a pseudocystic or multicystic appearance, strongly hypointense on T1-weighted and hyperintense on T2-weighted images (). Tumor subtypes may be recognizable on MRI allowing simple and complex histologic forms to be differentiated from nonspecific forms (). In our case series, all six patients were type 1 according to MRI classification. Surgical series report favorable outcomes in 70% to 90% of cases (, , , -). Surgical methods consist of lesionectomy or corticectomy, including amygdalo-hippocampectomy and anterior temporal lobectomy. In our six-case series, we performed lesionectomy, including removal of the uncus and temporal ventricular part of amygdala that were involved by the tumor. We noticed that all lesions were sharply delineated from the hippocampus and could be dissected leaving the hippocampus intact. We found that important for patient postoperative neurophysiological functioning, although we did not perform postoperative neurophysiological examination. Whether surgical outcome is related to the size of resection or type of the procedure remains controversial. Complete tumor removal is considered a major prognostic factor in most studies (, , , , ). Incomplete resection is identified as the main cause of surgical failure (). In our three patients, we did not resect the part of the lesion in the extra-ventricular portion of amygdala towards the basal ganglia in order not to damage basal ganglia. Nevertheless, all three patients were seizure-free postoperatively. Surgical failure has also been attributed to the presence of dysplastic cortex adjacent to the tumor. Removing these areas has been considered necessary for a favorable outcome (, ), but this has been contradicted by others (, ). Lesionectomy alone in temporal lobe epilepsy has been associated with a less favorable outcome than anterior temporal lobectomy (). This may be explained by the network organization of the epileptogenic zone and hippocampal involvement in tumors with temporal location (, ). Although we performed lesionectomy in all six patients, seizure outcome was favorable in all cases. The second major prognostic factor has been related to young age at surgery and short epilepsy duration (, , , ). In our series, median epilepsy duration was 13.2 years due to the fact that we had two adults aged 43 and 40 years with long epilepsy duration. In contrast, another four patients were younger and were seizure-free even after AED withdrawal. This is in accordance with the finding reported by Fay-McClymont et al. that successful AED discontinuation was also related to early surgery in young subjects (, ). No tumor recurrence was noticed during the follow-up in our series, despite those three patients with tumor remnants. In their large series, Campos et al. found that recurrence was rare and occurred at the site of residual tumor (). These findings advocate performing complete tumor resection whenever possible. In conclusion, DNETs are found in about 20% of the histologic diagnoses in adult epilepsy surgery centers. Complete tumor removal is considered a major prognostic factor. In our case series, all patients underwent lesionectomy leaving the hippocampus and parahippocampus intact with favorable seizure outcome achieved in all cases.
  19 in total

1.  Long-term seizure outcome following surgery for dysembryoplastic neuroepithelial tumor.

Authors:  Chow Huat Chan; Richard G Bittar; Gavin A Davis; Renate M Kalnins; Gavin C A Fabinyi
Journal:  J Neurosurg       Date:  2006-01       Impact factor: 5.115

2.  Predictors of outcome and pathological considerations in the surgical treatment of intractable epilepsy associated with temporal lobe lesions.

Authors:  M J Hennessy; R D Elwes; M Honavar; S Rabe-Hesketh; C D Binnie; C E Polkey
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-04       Impact factor: 10.154

Review 3.  Dysembryoplastic Neuroepithelial Tumors: What You Need to Know.

Authors:  Sabino Luzzi; Angela Elia; Mattia Del Maestro; Samer K Elbabaa; Sergio Carnevale; Francesco Guerrini; Massimo Caulo; Patrizia Morbini; Renato Galzio
Journal:  World Neurosurg       Date:  2019-04-11       Impact factor: 2.104

Review 4.  Dysembryoplastic neuroepithelial tumours.

Authors:  C Daumas-Duport
Journal:  Brain Pathol       Date:  1993-07       Impact factor: 6.508

Review 5.  The Children's Cancer and Leukaemia Group guidelines for the diagnosis and management of dysembryoplastic neuroepithelial tumours.

Authors:  D F O'Brien; M Farrell; N Delanty; H Traunecker; R Perrin; M D Smyth; T S Park
Journal:  Br J Neurosurg       Date:  2007-12       Impact factor: 1.596

6.  Seizure control outcomes after resection of dysembryoplastic neuroepithelial tumor in 50 patients.

Authors:  Edward F Chang; Catherine Christie; Joseph E Sullivan; Paul A Garcia; Tarik Tihan; Nalin Gupta; Mitchel S Berger; Nicholas M Barbaro
Journal:  J Neurosurg Pediatr       Date:  2010-01       Impact factor: 2.375

7.  Surgery for epilepsy in children with dysembryoplastic neuroepithelial tumor: clinical spectrum, seizure outcome, neuroradiology, and pathology.

Authors:  Burçak Bilginer; Dilek Yalnizoglu; Figen Soylemezoglu; Guzide Turanli; Ayşenur Cila; Meral Topçu; Nejat Akalan
Journal:  Childs Nerv Syst       Date:  2008-12-05       Impact factor: 1.475

8.  Dysembryoplastic neuroepithelial tumors in childhood: long-term outcome and prognostic features.

Authors:  M A Nolan; R Sakuta; N Chuang; H Otsubo; J T Rutka; O C Snead; C E Hawkins; S K Weiss
Journal:  Neurology       Date:  2004-06-22       Impact factor: 9.910

9.  Dysembryoplastic neuroepithelial tumor: a clinicopathological study of 32 cases.

Authors:  Mehar Chand Sharma; Deepali Jain; Aditya Gupta; Chitra Sarkar; Vaishali Suri; Ajay Garg; S B Gaikwad; P Sarat Chandra
Journal:  Neurosurg Rev       Date:  2009-01-23       Impact factor: 3.042

Review 10.  The 2007 WHO classification of tumours of the central nervous system.

Authors:  David N Louis; Hiroko Ohgaki; Otmar D Wiestler; Webster K Cavenee; Peter C Burger; Anne Jouvet; Bernd W Scheithauer; Paul Kleihues
Journal:  Acta Neuropathol       Date:  2007-07-06       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.